All News

Filter by

News Type
Topic
Language
Published Date

Filter by News Type

Done

Filter by Topic

Done

Filter by Language

Done

Filter by Published Date

Done
|
Media Availability
WHAT: A new study shows that the drug fenofibrate might reduce the risk of cardiovascular events in patients with type 2 diabetes who have high levels of triglycerides and low levels of “good” cholesterol, despite being treated with statins. The study, funded by the National Heart, Lung, and Blood Institute (NHLBI), appears in the December 28 issue...
|
Media Advisory
WHAT: Researchers at the National Institutes of Health have identified seven new areas of the genome linked to body fat distribution—a finding that could offer new insights into the biologic mechanisms that influence a person’s risk for diabetes, heart disease and stroke. The study, which included more than 18,000 individuals of European, African,...
|
Media Advisory
WHAT : A protein known to promote allergic diseases in people helps the body defend against Staphylococcus aureus , a leading cause of bacterial skin infections in the United States, according to a study appearing in the November 18 issue of Science Immunology. The study authors from the National Heart, Lung, and Blood Institute (NHLBI) say the fin...
|
Media Advisory
NIH-supported finding may help improve diagnosis, treatment of alcoholism WHAT: A team of researchers led by NIH scientists from the Framingham Heart Study says it has identified a group of new chemical markers in the blood that could provide the basis for the first reliable blood test to detect heavy alcohol use. In addition to screening ordinary...
surgery assistant nurse working
|
News Release
Researchers at the National Institutes of Health (NIH) have developed a new, less invasive way to perform transcatheter aortic valve replacement (TAVR), a procedure widely used to treat aortic valve stenosis, a lethal heart condition. The new approach, called transcaval access, will make TAVR more available to high risk patients, especially women,...
3D illustration of Lungs
|
News Release
Study addresses long-standing question for those with moderately low blood oxygen levels Newly published data from the Long-Term Oxygen Treatment Trial (LOTT) show that oxygen use is not beneficial for most people with chronic obstructive pulmonary disease (COPD) and moderately low levels of blood oxygen. It neither boosted their survival nor reduc...
Scientist holding pipette working microscope
|
Media Availability
WHAT: In a bold step for precision medicine, researchers at the National, Heart, Lung, and Blood Institute (NHLBI) today announced they are releasing for study nearly 9,000 whole genomes, courtesy of participants in the Institute’s Trans-Omics for Precision Medicine Program (TOPMed). The genomes—an organism’s complete set of DNA—are the first ever...
|
Media Advisory
Program aims to identify barriers and close gaps that limit patient access to consistent, quality care WHAT: The National Heart, Lung, and Blood Institute (NHLBI) recently awarded nearly $36 million in grants to help improve the quality of health care for U.S. teens and adults with sickle cell disease. The grants are the first of their kind dedicat...
stethoscope and heart
|
Media Advisory
WHAT: The National Heart, Lung, and Blood Institute (NHLBI) announces selection of Director of its Division of Cardiovascular Sciences (DCVS). WHO: David C. Goff, Jr., M.D., Ph.D. WHEN: Dr. Goff will start his new position at NHLBI on November 28, 2016. WHERE: NHLBI of the National Institutes of Health BRIEF BIOGRAPHY OF DR. GOFF: Dr. Goff was high...